Tang H - Search Results

1

miR-200c inhibits breast cancer proliferation by targeting KRAS.

Song C, Liu LZ, Pei XQ, Liu X, Yang L, Ye F, Xie X, Chen J, Tang H, Xie X. Song C, et al. Among authors: tang h. Oncotarget. 2015 Oct 27;6(33):34968-78. doi: 10.18632/oncotarget.5198. Oncotarget. 2015. PMID: 26392416 Free PMC article.

2

Interaction of hsa-miR-381 and glioma suppressor LRRC4 is involved in glioma growth.

Tang H, Liu X, Wang Z, She X, Zeng X, Deng M, Liao Q, Guo X, Wang R, Li X, Zeng F, Wu M, Li G. Tang H, et al. Brain Res. 2011 May 16;1390:21-32. doi: 10.1016/j.brainres.2011.03.034. Epub 2011 Mar 22. Brain Res. 2011. PMID: 21435336

3

POTEH hypomethylation, a new epigenetic biomarker for glioma prognosis.

Liu X, Tang H, Zhang Z, Li W, Wang Z, Zheng Y, Wu M, Li G. Liu X, et al. Among authors: tang h. Brain Res. 2011 May 19;1391:125-31. doi: 10.1016/j.brainres.2011.03.042. Epub 2011 Mar 22. Brain Res. 2011. PMID: 21439273

4

miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma.

Deng M, Tang H, Zhou Y, Zhou M, Xiong W, Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, Li X, Ma J, Li G. Deng M, et al. Among authors: tang h. J Cell Sci. 2011 Sep 1;124(Pt 17):2997-3005. doi: 10.1242/jcs.085050. J Cell Sci. 2011. PMID: 21878506

5

MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma.

Zhang Z, Tang H, Wang Z, Zhang B, Liu W, Lu H, Xiao L, Liu X, Wang R, Li X, Wu M, Li G. Zhang Z, et al. Among authors: tang h. Mol Cancer. 2011 Sep 30;10:124. doi: 10.1186/1476-4598-10-124. Mol Cancer. 2011. PMID: 21962230 Free PMC article.

6

F10 gene hypomethylation, a putative biomarker for glioma prognosis.

Liu X, Tang H, Wang Z, Huang C, Zhang Z, She X, Wu M, Li G. Liu X, et al. Among authors: tang h. J Neurooncol. 2012 May;107(3):479-85. doi: 10.1007/s11060-011-0775-2. Epub 2011 Dec 13. J Neurooncol. 2012. PMID: 22160665

7

LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway.

Tang H, Wang Z, Liu X, Liu Q, Xu G, Li G, Wu M. Tang H, et al. Curr Cancer Drug Targets. 2012 Oct;12(8):1032-42. doi: 10.2174/156800912803251180. Curr Cancer Drug Targets. 2012. PMID: 22834685

8

miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.

Deng M, Ye Q, Qin Z, Zheng Y, He W, Tang H, Zhou Y, Xiong W, Zhou M, Li X, Yan Q, Ma J, Li G. Deng M, et al. Among authors: tang h. Tumour Biol. 2013 Jun;34(3):1793-800. doi: 10.1007/s13277-013-0718-y. Epub 2013 Mar 13. Tumour Biol. 2013. PMID: 23479198

9

Low expression of tyrosine-protein phosphatase nonreceptor type 12 is associated with lymph node metastasis and poor prognosis in operable triple-negative breast cancer.

Wu MQ, Hu P, Gao J, Wei WD, Xiao XS, Tang HL, Li X, Ge QD, Jia WH, Liu RB, Xie XM. Wu MQ, et al. Asian Pac J Cancer Prev. 2013;14(1):287-92. doi: 10.7314/apjcp.2013.14.1.287. Asian Pac J Cancer Prev. 2013. PMID: 23534739 Free article.

10

MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1.

Gao J, Li L, Wu M, Liu M, Xie X, Guo J, Tang H, Xie X. Gao J, et al. Among authors: tang h. PLoS One. 2013 Jun 4;8(6):e65138. doi: 10.1371/journal.pone.0065138. Print 2013. PLoS One. 2013. PMID: 23750239 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,601 results

Search Page

Filters